Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Tuberculosis Research and Epidemiology, Diagnosis and treatment of tuberculosis, Pneumonia and Respiratory Infections, and Parasitic Diseases Research and Treatment.
Transmission modeling to infer tuberculosis incidence prevalence and mortality in settings with generalized HIV epidemics
Bayesian evidence synthesis to estimate subnational TB incidence: An application in Brazil
Global Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets - Worldwide, 2018.
Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data.
The second national tuberculosis prevalence survey in Vietnam.
Predicted impact of the COVID-19 pandemic on global tuberculosis deaths in 2020
Monitoring the status of selected health related sustainable development goals: methods and projections to 2030.
Global Epidemiology of Tuberculosis and Progress Toward Achieving Global Targets - 2017.
Guidance for the Evaluation of Tuberculosis Diagnostics That Meet the World Health Organization (WHO) Target Product Profiles: An Introduction to WHO Process and Study Design Principles.
Improving the quality of modelling evidence used for tuberculosis policy evaluation
Prevention of tuberculosis in household members: estimates of children eligible for treatment.
Improving the quality of modelling evidence used for tuberculosis policy evaluation.
The impact of social protection and poverty elimination on global tuberculosis incidence: a statistical modelling analysis of Sustainable Development Goal 1
Global tuberculosis targets and milestones set for 2016–2035: definition and rationale
Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study
End TB strategy: the need to reduce risk inequalities
Towards tuberculosis elimination: an action framework for low-incidence countries
Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries
Using the TIME model in Spectrum to estimate tuberculosis–HIV incidence and mortality
Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts
Analysis of tuberculosis prevalence surveys: new guidance on best-practice methods